Seven Grand Managers’s Silence Therapeutics SLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.73M Buy
+250,000
New +$3.04M 0.1% 97

Other funds holding SLN

Seven Grand Managers's SLN Position: Q3 2026 in Review

Seven Grand Managers opened a new position in Silence Therapeutics (SLN) in Q3 2026: 250,000 shares worth $2.73M. The stake represents 0.1% of the portfolio and ranks #97 among its holdings.

92 funds tracked by Wall St. Rank hold SLN as of Q3 2026.

  • Seven Grand Managers held 250,000 shares of Silence Therapeutics worth $2.73M as of Q3 2026.
  • Silence Therapeutics was a new Seven Grand Managers position in Q3 2026.
  • Silence Therapeutics made up 0.1% of Seven Grand Managers's portfolio in Q3 2026, its #97 holding.
  • 92 funds tracked by Wall St. Rank held Silence Therapeutics as of Q3 2026.

Based on Seven Grand Managers's 13F filing for Q3 2026, filed 16 Nov 2026.